J. Wilhelm

Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model.

P. Chanda, A. Davis, M. Lubeck, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Comparison of VSV Pseudovirus and Focus Reduction Neutralization Assays for Measurement of Anti-Andes orthohantavirus Neutralizing Antibodies in Patient Samples

C. Vial, G. Mertz, J. Botten, 2020, Frontiers in Cellular and Infection Microbiology.

Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees.

P. Chanda, S. Mizutani, M. Lubeck, 1993, AIDS research and human retroviruses.

Ultrastructural characterization of human immunodeficiency virus type 1 Gag-containing particles assembled in a recombinant adenovirus vector system.

P. Chanda, P. Hung, S. Lee, 1991, The Journal of general virology.

Immunogenicity of recombinant influenza virus haemagglutinin carrying peptides from the envelope protein of human immunodeficiency virus type 1.

A. Davis, P. Hung, M. Robert-Guroff, 1994, Vaccine.